FDA Advisory Committee Votes to Recommend Additional Data for Sintilimab Submission
SAN FRANCISCO, and SUZHOU, China, Feb. 11, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) held a public Oncology Drug Advisory Committee (ODAC) for sintilimab, which is under review for the first-line treatment of people with non-squamous non-small cell lung cancer (nsqNSCLC) based on the ORIENT-11 trial conducted exclusively in China. On the single voting question, the advisory committee voted...
WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories
SHANGHAI, Feb. 11, 2022 /PRNewswire/ -- WuXi STA, a subsidiary of WuXi AppTec, today announced that it received 2022 CMO Leadership Awards in all six core categories including Capabilities, Compatibility, Expertise, Quality, Reliability and Service and scored as a 2022 CMO Leadership Award Champion in four core categories. It is the eighth year that WuXi STA has been selected...
Alphamab Oncology Announced IND Approval of PD-L1/OX40 Bispecific Antibody KN052
SUZHOU, China, Feb. 11, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced, that the company received the IND approval from the National Medical Products Administration (NMPA) for the company's innovative bispecific antibody KN052 (PD-L1/OX40 bispecific antibody) to initiate clinical trials for the treatment of advanced solid tumors. Currently, there is no PD-(L)1/OX40 bispecific antibody approved for marketing worldwide. With...
Zimmer Biomet Opens ZBEdge Customer Experience Centre in Singapore to Drive Robotics and Medical Technology Transformation
SINGAPORE, Feb. 11, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today celebrated the opening of the ZBEdge Customer Experience Centre (CEC), a unique facility located at the company's Asia Pacific regional headquarters in Singapore. The ZBEdge Customer Experience Centre is a state-of-the-art facility...
Ucello Therapeutics Completes US$25 Million Series A Financing
SAN DIEGO, Calif. and CHENGDU, China, Feb. 11, 2022 /PRNewswire/ -- Ucello Therapeutics ("Ucello"), a biotechnology company developing universal CAR-T therapies, announced the successful completion of a US$25 million Series A financing. The funding round was led by Matrix Partners China, along with other investors Co-Win Ventures, Northern Light Venture Capital, and Elikon Venture. Also joining the round...
GLOBAL HEALTH TECHNOLOGY PLATFORM, PROXIMIE, ANNOUNCES NEW SENIOR APPOINTMENTS, BUILDING ON ITS STRONG START TO 2022
General Manager for the Americas - Charles H. Wilhelm, and Chief Growth Officer - Dave Herrmann, appointed BOSTON, Feb. 10, 2022 /PRNewswire/ -- Proximie, the global health technology platform digitizing operating rooms (OR) around the world, announces the appointments of a General Manager for the Americas, and a Chief Growth Officer - as it continues its rapid growth and impressive...
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
SEOUL, South Korea, Feb. 10, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, today announced that it has signed a supply deal with the Ministry of Health of Brazil to deliver four million COVID-19 tests. Since January 2022, Brazil has battled a 'twindemic,' a rapid surge...
AKESO’S NGF MONOCLONAL ANTIBODY (AK115) APPROVED TO INITIATE CLINICAL TRIAL IN PAIN (INCLUDING CANCER PAIN)
HONG KONG, Feb. 10, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that the clinical trial application of the innovative nerve growth factor (NGF) monoclonal antibody (research and development code: AK115) injection developed in-house by the Company, has obtained approval from the Centre for Drug Evaluation of China's National Medical Products Administration to begin clinical trial for the treatment...
WARBURG PINCUS ANNOUNCES ACQUISITION OF PHARMA INTELLIGENCE FROM INFORMA
LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Mubadala Investment Company, the Abu Dhabi based investment...
GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability
SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK), the world's leading life science research tools and services provider, today announced the opening of more than 30,000-square-feet facility for highly automated protein and gene preparation services. The state-of-the-art site marks a significant expansion of the company's advanced protein and gene platforms, and is designed to provide high...
